Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis
- PMID: 36151335
- DOI: 10.1007/s00134-022-06883-y
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis
Abstract
Purpose: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy and source control.
Methods: Post hoc analysis of a multicenter observational study (Abdominal Sepsis Study, AbSeS) including 2621 adult ICU patients with intra-abdominal infection in 306 ICUs from 42 countries. Time-till-source control intervention was calculated as from time of diagnosis and classified into 'emergency' (< 2 h), 'urgent' (2-6 h), and 'delayed' (> 6 h). Relationships were assessed by logistic regression analysis and reported as odds ratios (OR) and 95% confidence interval (CI).
Results: The cohort included 1077 cases of microbiologically confirmed secondary peritonitis. Mortality was 29.7%. The rate of appropriate empiric therapy showed no difference between survivors and non-survivors (66.4% vs. 61.3%, p = 0.1). A stepwise increase in mortality was observed with increasing Sequential Organ Failure Assessment (SOFA) scores (19.6% for a value ≤ 4-55.4% for a value > 12, p < 0.001). The highest odds of death were associated with septic shock (OR 3.08 [1.42-7.00]), late-onset hospital-acquired peritonitis (OR 1.71 [1.16-2.52]) and failed source control evidenced by persistent inflammation at day 7 (OR 5.71 [3.99-8.18]). Compared with 'emergency' source control intervention (< 2 h of diagnosis), 'urgent' source control was the only modifiable covariate associated with lower odds of mortality (OR 0.50 [0.34-0.73]).
Conclusion: 'Urgent' and successful source control was associated with improved odds of survival. Appropriateness of empirical antimicrobial treatment did not significantly affect survival suggesting that source control is more determinative for outcome.
Trial registration: ClinicalTrials.gov NCT03270345.
Keywords: Antimicrobial therapy; Intra-abdominal infection; Mortality; Secondary peritonitis; Source control.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt C, Rello J, Klompas M, Depuydt P, Eckmann C, Martin-Loeches I, Povoa P, Bouadma L, Timsit J, Zahar J (2022) Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 70:103227 - DOI
-
- Solomkin J, Mazuski J, Bradley J, Rodvold K, Goldstein E, Baron E, O’Neill P, Chow A, Dellinger E, Eachempati S, Gorbach S, Hilfiker M, May A, Nathens A, Sawyer R, Bartlett J (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 11:79–109 - DOI
-
- Sartelli M, Chichom-Mefire A, Labricciosa F, Hardcastle T, Abu-Zidan F, Adesunkanmi A, Ansaloni L, Bala M, Balogh Z, Beltrán M, Ben-Ishay O, Biffl W, Birindelli A, Cainzos M, Catalini G, Ceresoli M, Jusoh AC, Chiara O, Coccolini F, Coimbra R, Cortese F, Demetrashvili Z, Di Saverio S, Diaz J, Egiev V, Ferrada P, Fraga G, Ghnnam W, Lee J, Gomes C, Hecker A, Herzog T, Kim J, Inaba K, Isik A, Karamarkovic A, Kashuk J, Khokha V, Kirkpatrick A, Kluger Y, Koike K, Kong V, Leppaniemi A, Machain G, Maier R, Marwah S, McFarlane M, Montori G, Moore E, Negoi I, Olaoye I, Omari A, Ordonez C, Pereira B, Pereira Júnior G, Pupelis G, Reis T, Sakakhushev B, Sato N, Segovia Lohse H, Shelat V, Søreide K, Uhl W, Ulrych J, Van Goor H, Velmahos G, Yuan K, Wani I, Weber D, Zachariah S, Catena F (2017) The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 12:36 - DOI
-
- Vincent J, Rello J, Marshall J, Silva E, Anzueto A, Martin C, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329 - DOI
-
- Kübler A, Adamik B, Ciszewicz-Adamiczka B, Ostrowska E (2015) Severe sepsis in intensive care units in Poland—a point prevalence study in 2012 and 2013. Anaesthesiol Intensive Ther 47:315–319 - DOI
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical